FDA Crackdown: Cipla Arm Loses Pune Drug Sales Licence For Storage Deficiencies, Illegal Ads

As reported by NDTV Profit - Latest

The cancellation took effect from August 27, according to the Maharashtra FDA's action against the company's Pune operations.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

INDIAN US stocks today: US stocks open subdued ahead of Warsh's speech Markets-Economic Times
INDIAN Sebi bars Trafiksol ITS, promoters from securities market for one year Share Market Today
INDIAN Prestige launches new residential project 'Palm Court' in North Chennai Share Market Today
INDIAN Aditya Birla Capital allots 1.41 lakh equity shares under ESOP Share Market Today
INDIAN Centre announces ₹30,000 crore govt securities buyback via auction Share Market Today
INDIAN Bond yields hit over two-month high; rupee gains on RBI intervention Share Market Today
INDIAN Coforge expands partnership with Pega Share Market Today
INDIAN Pulse of the Street: Foreign buying fails to break August stalemate in Indian equities mint - markets

FDA Crackdown: Cipla Arm Loses Pune Drug Sales Licence For Storage Deficiencies, Illegal Ads

More from Market Samachar